Skip to main content

Table 5 Multivariate analysis for survival

From: The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy

Parameters

Hazard ratio

95% confidence interval

P value

5-year-DFS

EZH2

2.287

1.137-4.602

0.020

pT

2.244

1.076-4.678

0.013

pN

2.532

1.292-4.961

0.007

5-year-OS

   

EZH2

2.182

0.940-5.064

0.069

pT

2.395

0.997-5.365

0.051

pN

2.471

1.138-5.364

0.022